InformationGSK'963 GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase (RIPK1) with an IC50 of 29 nM in FP binding assays. It is >10 000-fold selective for RIP1 over 339 other kinases.TargetsRIP1 kinase (Cell-free assay) 29 nMIn vitroGSK/'963 inhibits RIP1-dependent cell death with an IC50 of between 1 and 4/u2009nM in human and murine cells.In vivoGSK/'963 is a potent inhibitor of a TNF+zVAD-mediated lethal shock. At 2/u2009mg/kg, GSK/'963 would maintain blood concentrations above the concentration required for 90% inhibition of RIP1 activity for an extended period of time compared with Nec-1.Cell Research(from reference)Cell lines:BMDM Concentrations:100/u2009nM Incubation Time:30 min.
Specifications and Purity: ≥98%
Molecular Formula: C14H18N2O
Molecular Weight: 230.31
PubChem CID: 122703613
Isomeric SMILES: CC(C)(C)C(=O)N1[C@@H](CC=N1)C2=CC=CC=C2
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/G414090-SCI_b045050034d8eea0b81d0b5e2b7dae0d.pdf
- UPC:
- 10171605
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- G414090-5mg
- CAS:
- 2049868-46-2
- Product Size:
- 5mg
- Hazard Statement Codes:
- H335:H319:H315:H302
- Precautionary Statement Codes:
- P305+P351+P338:P261
akash.verma@cenmed.com
(732) 447-1115





